Survival doses of chemotherapy or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Cells, Cultured Bone Marrow

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL

Diseases67

Radiation Injuries Breast Neoplasms Neoplasm Recurrence, Local Lung Neoplasms Neoplasms Radiation Injuries, Experimental Radiation Pneumonitis Adenocarcinoma Neoplasms, Radiation-Induced Brain Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Ovarian Neoplasms Colorectal Neoplasms Hodgkin Disease Lymphoma, Non-Hodgkin Liver Neoplasms Recurrence Head and Neck Neoplasms Lymphatic Metastasis Neutropenia Bone Neoplasms Disease Progression Carcinoma Vomiting Nausea Testicular Neoplasms Osteosarcoma Stomach Neoplasms Sarcoma Acute Radiation Syndrome Pancreatic Neoplasms Neoplasms, Germ Cell and Embryonal Lymphoma Glioblastoma Peritoneal Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukopenia Glioma Leukemia, Myeloid, Acute Leukemia, Radiation-Induced Rectal Neoplasms Neoplasms, Second Primary Esophageal Neoplasms Germinoma Melanoma Thrombocytopenia Colonic Neoplasms Radiodermatitis Nasopharyngeal Neoplasms Disease Models, Animal Multiple Myeloma Central Nervous System Neoplasms Stomatitis Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Neoplasm Invasiveness Skin Neoplasms Medulloblastoma Retroperitoneal Neoplasms Soft Tissue Neoplasms Hematologic Diseases Urinary Bladder Neoplasms Cerebellar Neoplasms Leukemia Mesothelioma

Chemicals and Drugs59

Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Etoposide Methotrexate Paclitaxel Carboplatin Vinblastine Taxoids Deoxycytidine Antimetabolites, Antineoplastic Bleomycin Antineoplastic Agents, Alkylating Ifosfamide Organoplatinum Compounds Radiation-Sensitizing Agents Tumor Markers, Biological Cytarabine Radiation-Protective Agents Dacarbazine Antineoplastic Agents, Phytogenic Anthracyclines Antibiotics, Antineoplastic Antibodies, Monoclonal Camptothecin Carmustine Lomustine Antibodies, Monoclonal, Humanized Cobalt Radioisotopes Melphalan Granulocyte Colony-Stimulating Factor Platinum Compounds Mitomycin Mitoxantrone Tegafur Tumor Suppressor Protein p53 Daunorubicin Thiotepa Antiemetics Radiopharmaceuticals Recombinant Proteins Receptor, erbB-2 Vindesine Bridged Compounds Antibodies, Monoclonal, Murine-Derived Platinum Cesium Radioisotopes Prednisolone Receptors, Estrogen Oxonic Acid Radioisotopes Dexamethasone Angiogenesis Inhibitors Fluorouracil RNA, Messenger Antineoplastic Agents, Hormonal Tamoxifen Quinazolines

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Survival Rate Radiation Dosage Disease-Free Survival Combined Modality Therapy Dose-Response Relationship, Radiation Treatment Outcome Survival Analysis Radiation Monitoring Neoplasm Staging Prognosis Radiotherapy Drug Administration Schedule Neoadjuvant Therapy Radiotherapy Dosage Follow-Up Studies Kaplan-Meier Estimate Radiotherapy, Adjuvant Radiation Injuries, Experimental Radiometry Dose Fractionation Prospective Studies Induction Chemotherapy Proportional Hazards Models Retrospective Studies Salvage Therapy Clinical Trials as Topic Multivariate Analysis Transplantation, Autologous Infusions, Intravenous Chemoradiotherapy Radiotherapy, Intensity-Modulated Chemotherapy, Cancer, Regional Perfusion Radiotherapy, Conformal Tomography, X-Ray Computed Risk Factors Immunohistochemistry Cranial Irradiation Actuarial Analysis Palliative Care Administration, Oral Randomized Controlled Trials as Topic Hematopoietic Stem Cell Transplantation Cohort Studies Radiotherapy Planning, Computer-Assisted Brachytherapy Whole-Body Irradiation Predictive Value of Tests Infusions, Intra-Arterial Risk Assessment Feasibility Studies Hyperthermia, Induced Radiotherapy, High-Energy Drug Therapy Bone Marrow Transplantation Body Burden Xenograft Model Antitumor Assays Tumor Burden Lethal Dose 50 Treatment Failure Clinical Trials, Phase III as Topic Radiation Hybrid Mapping Mastectomy Disease Models, Animal Positron-Emission Tomography Thermoluminescent Dosimetry Neoplasm Transplantation Analysis of Variance Drug Evaluation Random Allocation Models, Biological Radiosurgery Double-Blind Method Transplantation, Homologous Injections, Intravenous SEER Program Maintenance Chemotherapy Reverse Transcriptase Polymerase Chain Reaction Clinical Trials, Phase II as Topic Life Tables Pilot Projects Incidence

Phenomena and Processes28

Radiation Dosage Radiation, Ionizing Cell Survival Dose-Response Relationship, Radiation Radiation Tolerance Radiation Time Factors Graft Survival Cosmic Radiation Gamma Rays Apoptosis Drug Resistance, Neoplasm Background Radiation Ultraviolet Rays Radiation Effects Dose-Response Relationship, Drug DNA Damage X-Rays Signal Transduction Cell Proliferation Gene Expression Regulation, Neoplastic Lethal Dose 50 Mutation DNA Repair Linear Energy Transfer Drug Synergism Cell Cycle Cell Division

Disciplines and Occupations5

Radiation Oncology Immunohistochemistry Radiobiology Medical Oncology Radiation Genetics

Anthropology, Education, Sociology and Social Phenomena3

Survival Quality of Life Nuclear Warfare

Humanities1

Quality of Life

Information Science7

Survival Rate Radiotherapy, Intensity-Modulated Radiotherapy, Conformal Radiotherapy Planning, Computer-Assisted SEER Program Life Tables Incidence

Named Groups1

Health Care45

Survival Rate Radiation Dosage Radiation Injuries Disease-Free Survival Dose-Response Relationship, Radiation Treatment Outcome Survival Analysis Radiation Monitoring Radiation Protection Follow-Up Studies Kaplan-Meier Estimate Radiation Injuries, Experimental Cosmic Radiation Prospective Studies Proportional Hazards Models Retrospective Studies Ultraviolet Rays Clinical Trials as Topic Multivariate Analysis Radiation Effects Risk Factors Actuarial Analysis Palliative Care Randomized Controlled Trials as Topic Acute Radiation Syndrome Cohort Studies Age Factors Predictive Value of Tests Risk Assessment Feasibility Studies Radioactive Hazard Release Relative Biological Effectiveness Body Burden Treatment Failure Clinical Trials, Phase III as Topic Thermoluminescent Dosimetry Analysis of Variance Random Allocation Double-Blind Method SEER Program Radiation Genetics Clinical Trials, Phase II as Topic Life Tables Pilot Projects Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Survival Rate Radiation Dosage Radiation, Ionizing Radiation Injuries Cell Survival Disease-Free Survival Combined Modality Therapy Dose-Response Relationship, Radiation Treatment Outcome Survival Analysis Antineoplastic Agents Radiation Tolerance Radiation Cisplatin Radiation Monitoring Cyclophosphamide Doxorubicin Radiation Protection Neoplasm Staging Breast Neoplasms Survival Time Factors Prognosis Radiotherapy Drug Administration Schedule Neoadjuvant Therapy Radiotherapy Dosage Neoplasm Recurrence, Local Lung Neoplasms Etoposide Follow-Up Studies Radiation Oncology Neoplasms Graft Survival Kaplan-Meier Estimate Methotrexate Radiotherapy, Adjuvant Radiation Injuries, Experimental Paclitaxel Carboplatin Radiation Pneumonitis Radiometry Cosmic Radiation Vinblastine Gamma Rays Adenocarcinoma Neoplasms, Radiation-Induced Brain Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Taxoids Apoptosis Deoxycytidine Dose Fractionation Drug Resistance, Neoplasm Antimetabolites, Antineoplastic Prospective Studies Cell Line, Tumor Bleomycin Induction Chemotherapy Antineoplastic Agents, Alkylating Proportional Hazards Models Ifosfamide Organoplatinum Compounds Retrospective Studies Background Radiation Salvage Therapy Radiation-Sensitizing Agents Carcinoma, Squamous Cell Ovarian Neoplasms Ultraviolet Rays Tumor Markers, Biological Colorectal Neoplasms Cytarabine Hodgkin Disease Lymphoma, Non-Hodgkin Liver Neoplasms Radiation-Protective Agents Clinical Trials as Topic Dacarbazine Antineoplastic Agents, Phytogenic Multivariate Analysis Radiation Effects Recurrence Head and Neck Neoplasms Anthracyclines Lymphatic Metastasis Transplantation, Autologous Neutropenia Infusions, Intravenous Bone Neoplasms Chemoradiotherapy Disease Progression Radiotherapy, Intensity-Modulated Carcinoma Chemotherapy, Cancer, Regional Perfusion Radiotherapy, Conformal Tomography, X-Ray Computed

No FAQ available that match "survival doses of chemotherapy or radiation"